Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related MRK
Cramer Talks About Merck's 'Fabulous News' And Why The Market Can't Rally
Merck Rallies Of Drug Trial Results
2 Key FDA Actions On Potential Blockbuster Drugs Next Week (Investor's Business Daily)
Related JOY
FBR Upgrades Joy Global To Outperform, Lifts Target To $25
Benzinga's Top Upgrades
The Vetr community has upgraded $JOY to 2-Stars. (Vetr)

Analysts at MKM Partners upgraded Merck & Co (NYSE: MRK) from “neutral” to “buy.” Merck's shares closed at $43.34 yesterday. Merck's trailing-twelve-month revenue is $47.82 billion.

Analysts at BMO Capital upgraded Joy Global (NYSE: JOY) from “underperform” to “market perform.” Joy Global's stock closed at $57.07 yesterday. Joy Global's trailing-twelve-month operating margin is 21.17%.

Analysts at Jefferies upgraded Research In Motion Limited (NASDAQ: RIMM) from “underperform” to “hold.” Research In Motion's shares closed at $9.59 yesterday. Research In Motion had $2.06 billion in total cash for the latest quarter.

Analysts at Goldman Sachs upgraded Whole Foods Market (NASDAQ: WFM) from “neutral” to “buy.” Whole Foods Market's shares closed at $91.41 yesterday. Whole Foods Market's trailing-twelve-month ROE is 13.71%.

Latest Ratings for MRK

DateFirmActionFromTo
Jun 2016JefferiesMaintainsHold
May 2016Credit SuisseMaintainsNeutral
Apr 2016JefferiesMaintainsHold

View More Analyst Ratings for MRK
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (MRK + JOY)

View Comments and Join the Discussion!